These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 23055843)

  • 1. Y-site compatibility of medications with parenteral nutrition.
    Robinson CA; Lee JE
    J Pediatr Pharmacol Ther; 2007 Jan; 12(1):53-9. PubMed ID: 23055843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Physical compatibility of medications with concentrated neonatal and pediatric parenteral nutrition: A simulated Y-site drug compatibility study.
    Ross EL; Petty K; Salinas A; Her C; Carpenter JF
    JPEN J Parenter Enteral Nutr; 2023 Mar; 47(3):372-381. PubMed ID: 36582024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Compatibility of prolonged infusion antibiotics during Y-site administration.
    Nunez-Nunez M; Murillo-Izquierdo M; Moya-Martin M; Hoxha M; Quesada Pérez MT; Oltra-Hostalet F; Alonso-Ramos H; Cordero-Ramos J; Barrera-Cabeza J; Retamar-Gentil P; Fernández-Del-Castillo SS
    Nurs Crit Care; 2022 Nov; 27(6):849-858. PubMed ID: 35088491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Y-site physical compatibility of hydrocortisone continuous infusions with admixtures used in critically ill patients.
    Foushee JA; Meredith P; Fox LM; Wilder AG
    Am J Health Syst Pharm; 2020 Jul; 77(14):1144-1148. PubMed ID: 32537625
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Compatibility of intravenous medications with parenteral nutrition: in vitro evaluation.
    Bouchoud L; Fonzo-Christe C; Klingmüller M; Bonnabry P
    JPEN J Parenter Enteral Nutr; 2013; 37(3):416-24. PubMed ID: 23112277
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of the Physical Compatibility of Eravacycline and Common Parenteral Drugs During Simulated Y-site Administration.
    Avery LM; Chen IH; Reyes S; Nicolau DP; Kuti JL
    Clin Ther; 2019 Oct; 41(10):2162-2170. PubMed ID: 31506218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compatibility of medications with 3-in-1 parenteral nutrition admixtures.
    Trissel LA; Gilbert DL; Martinez JF; Baker MB; Walter WV; Mirtallo JM
    JPEN J Parenter Enteral Nutr; 1999; 23(2):67-74. PubMed ID: 10081995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Y-Site Compatibility Studies of Ketoprofen with Parenteral Nutrition Admixtures for Central and Peripheral Administration.
    Dettlaff K; Gostyńska A; Ziółkowska N; Stawny M
    Pharmaceutics; 2022 Nov; 14(12):. PubMed ID: 36559064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development and evaluation of a test program for Y-site compatibility testing of total parenteral nutrition and intravenous drugs.
    Staven V; Wang S; Grønlie I; Tho I
    Nutr J; 2016 Mar; 15():29. PubMed ID: 27000057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of Y-site compatibility of home total parenteral nutrition and intravenous loop diuretics.
    Watrobska-Swietlikowska D; Pietka M; Klek S
    Medicine (Baltimore); 2019 May; 98(21):e15747. PubMed ID: 31124957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability and compatibility of parenteral nutrition solutions; a review of influencing factors.
    Farhan M; McCallion N; Bennett J; Cram A; O'Brien F
    Eur J Pharm Biopharm; 2023 Jun; 187():87-95. PubMed ID: 37061100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Compatibility of pentoxifylline and parenteral medications.
    Campbell AL; Petrovski M; Senarathna SG; Mukadam N; Strunk T; Batty KT
    Arch Dis Child; 2020 Apr; 105(4):395-397. PubMed ID: 31871042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Y-site Incompatibility Between Premix Concentrations of Vancomycin and Piperacillin-Tazobactam: Do Current Compatibility Testing Methodologies Tell the Whole Story?
    Kufel WD; Miller CD; Johnson PR; Reid K; Zahra JJ; Seabury RW
    Hosp Pharm; 2017 Feb; 52(2):132-137. PubMed ID: 28321140
    [No Abstract]   [Full Text] [Related]  

  • 14. Avoidance of Overt Precipitation and Patient Harm Following Errant Y-Site Administration of Calcium Chloride and Parenteral Nutrition Compounded With Sodium Glycerophosphate.
    Anderson C; Stidham C; Boehme S; Cash J
    Nutr Clin Pract; 2018 Dec; 33(6):902-905. PubMed ID: 29730898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Utilization of the tyndall effect for enhanced visual detection of particles in compatibility testing of intravenous fluids: validity and reliability.
    Staven V; Waaseth M; Wang S; Grønlie I; Tho I
    PDA J Pharm Sci Technol; 2015; 69(2):270-83. PubMed ID: 25868993
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Investigations of Physical Compatibilities of Commonly Used Intravenous Medications with and without Parenteral Nutrition in Pediatric Cardiovascular Intensive Care Unit Patients.
    Greenhill K; Hornsby E; Gorman G
    Pharmaceuticals (Basel); 2019 May; 12(2):. PubMed ID: 31060247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Y-Site Compatibility of Intravenous Levetiracetam With Commonly Used Critical Care Medications.
    Lee TM; Villareal CL; Meyer LM
    Hosp Pharm; 2021 Aug; 56(4):282-286. PubMed ID: 34381262
    [No Abstract]   [Full Text] [Related]  

  • 18. Analysis of antibiotic stability in a parenteral nutrition solution.
    Kamen BA; Gunther N; Sowinsky N; Rizzo J; Marsik F
    Pediatr Infect Dis; 1985; 4(4):387-9. PubMed ID: 3927270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physicochemical Compatibility of Dexmedetomidine With Parenteral Nutrition.
    Campos-Baeta Y; Saavedra-Mitjans M; Garin N; Cardenete J; Cardona D; Riera P
    Nutr Clin Pract; 2020 Oct; 35(5):967-972. PubMed ID: 31482649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Y-site compatibility of medications with parenteral nutrition.
    Robinson CA; Sawyer JE
    J Pediatr Pharmacol Ther; 2009 Jan; 14(1):48-56. PubMed ID: 23055891
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.